Current status of quality of life measurement in lung cancer patients.
AffiliationDepartment of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, UK.
MetadataShow full item record
AbstractQuality of life in patients with inoperable lung cancer receiving palliative treatment has become an important issue. As in other types of cancer, lack of standardization of quality of life data makes comparison between trials difficult, sometimes even impossible. Much effort is being given to the development of suitable instruments to measure quality of life and strategies to incorporate these measurements into clinical trials. The authors review studies in palliative lung cancer treatment where two crucial questions are being addressed: Do patients improve in performance status and symptom relief and does treatment toxicity outweigh disease palliation?
CitationCurrent status of quality of life measurement in lung cancer patients. 1991, 5 (5):159-166; discussion 166, 169, 173 Oncology
- Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise.
- Authors: Stephens RJ, Hopwood P, Girling DJ
- Issue date: 1999 Feb
- The role of palliative care in the lung cancer patient: can we improve quality while limiting futile care?
- Authors: Freedman OC, Zimmermann C
- Issue date: 2009 Jul
- Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life.
- Authors: Gralla RJ
- Issue date: 2004
- Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment.
- Authors: Michael M, Tannock IF
- Issue date: 1998 Jun 30
- Receiving a diagnosis of inoperable lung cancer: patients' perspectives of how it affects their life situation and quality of life.
- Authors: Berterö C, Vanhanen M, Appelin G
- Issue date: 2008